Eisai expands UK manufacturing facility for specialized medicines
Eisai expands UK manufacturing facility for specialized medicines
Updated at: June 15, 2026 at 09:00 AM
Eisai, a prominent pharmaceutical company, has significantly expanded its manufacturing facility in Hatfield, Hertfordshire, cementing its position as a vital global supply hub.
Serving as the headquarters for EMEA, the site plays a critical role in integrating discovery, production, and marketing for specialized medicines.
Through strategic investments, the company has transformed its UK presence to better address the growing global demand for treatments, particularly for advanced cancers and neurological disorders.
Today, the Hatfield plant serves 73 countries, delivering over 30 different product formulations to roughly 500,000 patients annually.
By creating highly skilled jobs and incorporating cutting-edge technologies, Eisai’s commitment to the UK has been widely praised as a significant vote of confidence in the nation's competitive life sciences sector.
